Cargando…

Manipulating Protein Acetylation in Breast Cancer: A Promising Approach in Combination with Hormonal Therapies?

Estrogens play an essential role in the normal physiology of the breast as well as in mammary tumorigenesis. Their effects are mediated by two nuclear estrogen receptors, ERα and β, which regulate transcription of specific genes by interacting with multiprotein complexes, including histone deacetyla...

Descripción completa

Detalles Bibliográficos
Autores principales:	Linares, Aurélien, Dalenc, Florence, Balaguer, Patrick, Boulle, Nathalie, Cavailles, Vincent
Formato:	Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2011
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3004450/ https://www.ncbi.nlm.nih.gov/pubmed/21188173 http://dx.doi.org/10.1155/2011/856985

Ejemplares similares

Histone deacetylase 9 regulates breast cancer cell proliferation and the response to histone deacetylase inhibitors
por: Lapierre, Marion, et al.
Publicado: (2016)

Increased expression of the HDAC9 gene is associated with antiestrogen resistance of breast cancers
por: Linares, Aurélien, et al.
Publicado: (2019)

New stably transfected bioluminescent cells expressing FLAG epitope-tagged estrogen receptors to study their chromatin recruitment
por: Badia, Eric, et al.
Publicado: (2009)

Structural and Functional Profiling of Environmental Ligands for Estrogen Receptors
por: Delfosse, Vanessa, et al.
Publicado: (2014)

Endocrine Therapy for Breast Cancer: A Model of Hormonal Manipulation
por: Johnston, Simon J., et al.
Publicado: (2018)

Phase-specific manipulation of neuronal activity: a promising stroke therapy approach
por: Turner, Dennis A., et al.
Publicado: (2020)

Clinical relevance of "withdrawal therapy" as a form of hormonal manipulation for breast cancer
por: Agrawal, Amit, et al.
Publicado: (2011)

Recent Advances in Enhancing the Therapeutic Index of PARP Inhibitors in Breast Cancer
por: Franchet, Camille, et al.
Publicado: (2021)

Honokiol inhibits the growth of hormone-resistant breast cancer cells: its promising effect in combination with metformin
por: Mikhaevich, Ekaterina I., et al.
Publicado: (2023)

Cytoplasmic and Nuclear Forms of Thyroid Hormone Receptor β1 Are Inversely Associated with Survival in Primary Breast Cancer
por: Shao, Wanting, et al.
Publicado: (2020)

Combining two repurposed drugs as a promising approach for Alzheimer's disease therapy
por: Chumakov, Ilya, et al.
Publicado: (2015)

Combination Therapy, a Promising Approach to Enhance the Efficacy of Radionuclide and Targeted Radionuclide Therapy of Prostate and Breast Cancer
por: Damiana, Tyrillshall S. T., et al.
Publicado: (2021)

Immune microenvironment changes induced by neoadjuvant chemotherapy in triple-negative breast cancers: the MIMOSA-1 study
por: Sarradin, Victor, et al.
Publicado: (2021)

Combination of acamprosate and baclofen as a promising therapeutic approach for Parkinson’s disease
por: Hajj, Rodolphe, et al.
Publicado: (2015)

Biological response to hormonal manipulation in oestrogen receptor positive ductal carcinoma in situ of the breast
por: Boland, G P, et al.
Publicado: (2003)

RIP140 inhibits glycolysis-dependent proliferation of breast cancer cells by regulating GLUT3 expression through transcriptional crosstalk between hypoxia induced factor and p53
por: Jacquier, Valentin, et al.
Publicado: (2022)

The stake of informing patients of the risk of hypofertility after chemotherapy for breast cancer
por: Martinet-Kosinski, Florian, et al.
Publicado: (2023)

Fungal manipulation of hormone-regulated plant defense
por: Patkar, Rajesh N., et al.
Publicado: (2017)

Chaperoning steroid hormone signaling via reversible acetylation
por: Kovacs, Jeffrey J., et al.
Publicado: (2005)

A brief review of clinical trials involving manipulation of invariant NKT cells as a promising approach in future cancer therapies
por: Waldowska, Małgorzata, et al.
Publicado: (2017)

Manipulating NK cellular therapy from cancer to invasive fungal infection: promises and challenges
por: Oh, Bernice Ling Zhi, et al.
Publicado: (2023)

Effect of hormonal manipulation and doxorubicin administration on cell cycle kinetics of human breast cancer cells.
por: Bontenbal, M., et al.
Publicado: (1989)

Incidence of reversible amenorrhea in women with breast cancer undergoing adjuvant anthracycline-based chemotherapy with or without docetaxel
por: Berliere, Martine, et al.
Publicado: (2008)

Embryonic thermal manipulation impacts the postnatal transcriptome response of heat-challenged Japanese quails
por: Vitorino Carvalho, Anaïs, et al.
Publicado: (2021)

Access to information and oncofertility consultation for young women with breast cancer: a population-based study
por: Martinet-Kosinski, Florian, et al.
Publicado: (2023)

Calcium signaling: breast cancer’s approach to manipulation of cellular circuitry
por: Pratt, Stephen JP, et al.
Publicado: (2020)

“Veozah (Fezolinetant): A Promising Non‐Hormonal Treatment for Vasomotor Symptoms in Menopause”
por: Shaukat, Ayesha, et al.
Publicado: (2023)

Pre-Exposure Prophylaxis and the Promise of Combination Prevention Approaches
por: Buchbinder, Susan P., et al.
Publicado: (2011)

Drug acetylation in breast cancer.
por: Webster, D. J., et al.
Publicado: (1989)

Combined hormonal therapy for advanced breast cancer in postmenopausal patients
por: Langecker, P, et al.
Publicado: (2003)

Combination Therapies in Advanced, Hormone Receptor–Positive Breast Cancer
por: Olson, Emily
Publicado: (2018)

Ensemble Learning for Hormone Binding Protein Prediction: A Promising Approach for Early Diagnosis of Thyroid Hormone Disorders in Serum
por: Butt, Ahmad Hassan, et al.
Publicado: (2023)

Cytoplasmic Localization of Thyroid Hormone Receptor (TR) Alpha and Nuclear Expression of Its Isoform TRα2 Determine Survival in Breast Cancer in Opposite Ways
por: Schneider, Mariella, et al.
Publicado: (2023)

NANO-SBT-PEDF delivery system: A promising approach against ovarian cancer?
por: Ribaux, Pascale, et al.
Publicado: (2023)

PELICAN-IPC 2015-016/Oncodistinct-003: A Prospective, Multicenter, Open-Label, Randomized, Non-Comparative, Phase II Study of Pembrolizumab in Combination With Neo Adjuvant EC-Paclitaxel Regimen in HER2-Negative Inflammatory Breast Cancer
por: Bertucci, Alexandre, et al.
Publicado: (2020)

Regulation of intestinal homeostasis and tumorigenesis by the transcriptional coregulator RIP140
por: Cavaillès, Vincent, et al.
Publicado: (2014)

N-acetyl-L-leucine: a promising treatment option for traumatic brain injury
por: Sarkar, Chinmoy, et al.
Publicado: (2022)

The promise of growth hormone in sport: doped or duped
por: Ho, Ken K. Y.
Publicado: (2019)

Combinations of TLR Ligands: A Promising Approach in Cancer Immunotherapy
por: Stier, Saskia, et al.
Publicado: (2013)

Nab-paclitaxel and trastuzumab combination: a promising approach for neoadjuvant treatment in HER2-positive breast cancer
por: Ricciardi, Giuseppina Rosaria Rita, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_c0f0f6g1bpppvnfdmaeo46hjc7